Heart Valve Disease Clinical Trial
Official title:
Anticoagulation Treatment Influence on Post-operative Patients -Action SJM EPIC Trial
NCT number | NCT00187304 |
Other study ID # | CS04012TV |
Secondary ID | |
Status | Withdrawn |
Phase | Phase 4 |
First received | |
Last updated | |
Start date | September 2005 |
Verified date | February 2019 |
Source | Abbott Medical Devices |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary objective of this study is to compare two different regimens of therapy, AVK and ASA (aspirin), in the early postoperative period after aortic valve replacement with SJM Epic™ or SJM Epic™ Supra Porcine Bioprosthetic Heart Valve by establishing the adverse event free survival rate at 3 month post intervention follow-up of the 2 groups(with special focus on thromboembolic events and bleedings).
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Patient requires, for the first time, isolated aortic valve replacement (pacemaker insertion is allowed) 2. Patient (or legal guardian) has signed a study specific informed consent form agreeing to the data collection and follow-up requirements. 3. Patient is of legal age in the host country 4. The patient is in sinus rhythm before implantation Exclusion Criteria: 1. Patient already has a prosthetic valve, other than the valve being replaced at this time. 2. Patient requires double valve implantation 3. Patient requires concomitant CABG 4. Patients requires intra aortic balloon pump at intervention 5. Patient has a medical condition which contraindicates implantation of the SJM Epic and/or SJM Epic Supra Porcine Bioprosthetic Heart Valve (e.g. patient on dialysis) 6. Patient requires ASA or AVK therapy, i.e. not suitable for randomization 7. Patient is pregnant or nursing. 8. Patient is affected by active endocarditis. 9. Patient is affected by aortic dissection. 10. Patient has history of cerebral ischemia 11. Patient is affected by coagulopathy, history of GI bleeding or increased bleeding risk 12. Patient is affected by peripheral vascular disease requiring treatment 13. Patient has previous chronic anticoagulation therapy 14. Patient is allergic to ASA and/or AVK |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Abbott Medical Devices |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT02527629 -
Aortic Replacement Using Individualised Regenerative Allografts - ARISE (the "Surveillance")
|
||
Completed |
NCT01178710 -
Effect of Simvastatin on Cardiac Function
|
N/A | |
Completed |
NCT01426776 -
Effect of Heart Valve Replacement on Cheyne-Stokes Respiration
|
N/A | |
Completed |
NCT00581399 -
A Randomized Multicenter Clinical Study On the High Vacuum Body Cavity Drainage System Following Open Heart Surgery
|
Phase 2 | |
Terminated |
NCT00700947 -
Using Beta Blockers to Treat Mitral Regurgitation
|
Phase 1 | |
Recruiting |
NCT02574650 -
Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.
|
N/A | |
Recruiting |
NCT02650388 -
Frailty and Cognitive Function Assessment of TAVI Patients
|
Phase 4 | |
Completed |
NCT01996657 -
D-dimer and Oral Anticoagulation Therapy in Patients With Mechanical Valve Replacement
|
N/A | |
Terminated |
NCT00598936 -
A Prospective Study With a New Device for the Monitoring of Cerebral Oxygenation on Cardiac Surgery Patients
|
Phase 1 | |
Terminated |
NCT01812174 -
On-X Heart Valve - 17mm Aortic and 23mm Mitral
|
N/A | |
Recruiting |
NCT03225612 -
Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)
|
N/A | |
Completed |
NCT01384643 -
Effect of Propofol on Renal Injury in Patients Undergoing Valvular Heart Surgery
|
Phase 4 | |
Completed |
NCT01558765 -
CopenHeartVR - Integrated Rehabilitation of Patients After Heart Valve Surgery
|
Phase 2 | |
Active, not recruiting |
NCT00291525 -
Randomized On-X Anticoagulation Trial
|
N/A | |
Completed |
NCT02867930 -
Comparative Effects of Dexmedetomidine and Ketofol for Sedation in Patients Undergoing Trans-esophageal Echocardiography
|
Phase 4 | |
Recruiting |
NCT02478008 -
A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)
|
N/A | |
Completed |
NCT02790008 -
Magnetic Resonance Imaging and Fibrosis
|
||
Completed |
NCT02587039 -
An Intervention to Reduce Delirium After Cardiac Surgery
|
N/A | |
Recruiting |
NCT01855737 -
The Study of Warfarin Maintenance Dose in Chinese Patients
|
Phase 4 |